Image_8_Establishing a Prognostic Model Based on Ulceration and Immune Related Genes in Melanoma Patients and Identification of EIF3B as a Therapeutic Target.tif
Ulceration and immune status are independent prognostic factors for survival in melanoma patients. Herein univariate Cox regression analysis revealed 53 ulcer-immunity-related DEGs. We performed consensus clustering to divide The Cancer Genome Atlas (TCGA) cohort (n = 467) into three subtypes with different prognosis and biological functions, followed by validation in three merged Gene Expression Omnibus (GEO) cohorts (n = 399). Multiomics approach was used to assess differences among the subtypes. Cluster 3 showed relatively lesser amplification and expression of immune checkpoint genes. Moreover, Cluster 3 lacked immune-related pathways and immune cell infiltration, and had higher proportion of non-responders to immunotherapy. We also constructed a prognostic model based on ulceration and immune related genes in melanoma. EIF3B was a hub gene in the intersection between genes specific to Cluster 3 and those pivotal for melanoma growth (DepMap, https://depmap.org/portal/download/). High EIF3B expression in TCGA and GEO datasets was related to worst prognosis. In vitro models revealed that EIF3B knockdown inhibited melanoma cell migration and invasion, and decreased TGF-β1 level in supernatant compared with si-NC cells. EIF3B expression was negatively correlated with immune-related signaling pathways, immune cell gene signatures, and immune checkpoint gene expression. Moreover, its low expression could predict partial response to anti-PD-1 immunotherapy. To summarize, we established a prognostic model for melanoma and identified the role of EIF3B in melanoma progression and immunotherapy resistance development.
History
References
- https://doi.org//10.3322/caac.21565
- https://doi.org//10.3322/caac.21601
- https://doi.org//10.3322/caac.21637
- https://doi.org//10.1200/JCO.2011.37.8539
- https://doi.org//10.1200/JCO.2013.51.3002
- https://doi.org//10.1097/SLA.0b013e31824c4b0b
- https://doi.org//10.1016/S0140-6736(21)01206-X
- https://doi.org//10.1016/j.cell.2017.01.017
- https://doi.org//10.1200/JCO.2013.54.2340
- https://doi.org//10.1200/JCO.2013.50.1114
- https://doi.org//10.1016/j.cell.2018.10.038
- https://doi.org//10.3389/fimmu.2020.561390
- https://doi.org//10.1111/jdv.15302
- https://doi.org//10.1016/j.jid.2018.06.178
- https://doi.org//10.1001/jamanetworkopen.2021.26337
- https://doi.org//10.1093/nar/gkt510
- https://doi.org//10.1158/1078-0432.CCR-12-3084
- https://doi.org//10.1038/s41419-019-1846-0
- https://doi.org//10.1093/bioinformatics/btm254
- https://doi.org//10.1093/bioinformatics/bts034
- https://doi.org//10.1093/nar/gkv1507
- https://doi.org//10.1186/s13059-014-0550-8
- https://doi.org//10.1186/1471-2105-14-7
- https://doi.org//10.1016/j.immuni.2013.10.003
- https://doi.org//10.1093/bioinformatics/btq170
- https://doi.org//10.1371/journal.pone.0015543
- https://doi.org//10.1093/bioinformatics/btaa1018
- https://doi.org//10.1101/gr.239244.118
- https://doi.org//10.1038/ng0506-500
- https://doi.org//10.7554/eLife.26476
- https://doi.org//10.1007/978-1-4939-7493-1_12
- https://doi.org//10.1038/nmeth.3337
- https://doi.org//10.1186/s13059-016-1070-5
- https://doi.org//10.1186/s13073-019-0655-5
- https://doi.org//10.1186/1752-0509-8-S4-S11
- https://doi.org//10.1016/j.intimp.2020.106659
- https://doi.org//10.18637/jss.v033.i01
- https://doi.org//10.1111/j.2517-6161.1972.tb00899.x
- https://doi.org//10.1002/sim.6079
- https://doi.org//10.1002/wics.147
- https://doi.org//10.1093/bioinformatics/btw313
- https://doi.org//10.1038/onc.2008.271
- https://doi.org//10.1016/j.cell.2015.05.044
- https://doi.org//10.1016/j.ccell.2021.04.014
- https://doi.org//10.1093/annonc/mdy495
- https://doi.org//10.3389/fonc.2021.644156
- https://doi.org//10.1016/j.immuni.2013.07.012
- https://doi.org//10.1200/JCO.2001.19.16.3622
- https://doi.org//10.1200/JCO.2006.08.9755
- https://doi.org//10.1038/nature08638
- https://doi.org//10.1016/j.jaci.2013.07.006
- https://doi.org//10.1038/ncomms11037
- https://doi.org//10.1016/j.smim.2016.10.011
- https://doi.org//10.1016/j.ccell.2018.04.001
- https://doi.org//10.1016/j.cell.2011.02.013
- https://doi.org//10.1038/nature12988
- https://doi.org//10.1038/s41586-019-1914-8
- https://doi.org//10.1038/s41586-019-1922-8
- https://doi.org//10.1126/science.aao4572
- https://doi.org//10.1038/s41591-020-0818-3
- https://doi.org//10.1038/s41591-018-0157-9
- https://doi.org//10.1302/2046-3758.63.BJR-2016-0151.R2
- https://doi.org//10.1038/s41571-020-0403-1
- https://doi.org//10.1016/j.immuni.2019.03.024
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity